300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device Startup Investors in Asia (October 2023)

The most active venture capital funds and angel investors investing in Asia Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Medical Device startup companies. Find investors to raise a Series A, Series B or Series C round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Sequoia Capital China
VC Fund
10 China, United States, Australia Series A, Series B, Series C Health Care, Biotechnology, Artificial Intelligence $4M–$200M
Qiming Venture Partners
VC Fund
10 China, United States, Hong Kong Series B, Series A, Series C Health Care, Medical, Biotechnology $4.1M–$148M
Cowin Capital
VC Fund
9 China, Hong Kong, United States Series A, Series B, Series C Manufacturing, Health Care, Software $4.1M–$100M
CD Capital
VC Fund
9 China, United States Series A, Series B, Angel Health Care, Biotechnology, Medical Device $412k–$34M
Lilly Asia Ventures
VC Fund
8 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $11M–$275M
Haibang Capital
VC Fund
8 China Series A, Angel, Series B Health Care, Biotechnology, Medical $412k–$69M
BioTrack Capital
VC Fund
7 China, United States, Singapore Series A, Series B, Seed Health Care, Biotechnology, Medical
Addor Capital
VC Fund
6 China, Hong Kong, United States Series A, Series B Manufacturing, Medical, Electronics $1.4M–$41M
Legend Capital
VC Fund
6 China, United States, South Korea Series B, Series A, Series C Health Care, Biotechnology, Medical $2.7M–$200M
Marathon Venture Partners
VC Fund
5 China, Hong Kong, United States Series A, Series B, Angel Health Care, Medical, Biotechnology $412k–$462M
SZHTI Group
VC Fund
5 China, United States Series A, Angel Manufacturing, Electronics, Health Care $412k–$14M
BioVenture
VC Fund
5 China, United States, Taiwan Series A, Series B, Series C Health Care, Medical, Biotechnology $2.7M–$58M
Nippon Venture Capital
VC Fund
5 Japan, United States Series A, Seed Software, Health Care, Information Technology $6.8M–$112M
Share Capital
VC Fund
4 China, United States, Hong Kong Series A, Series B, Angel Medical, Health Care, Biotechnology $412k–$55M
Taiyu Investment
VC Fund
4 China Series A, Seed, Angel Medical, Health Care, Biotechnology $412k–$20M
IDG Capital
VC Fund
4 China, United States, India Series A, Series B, Series C Software, Internet, E-Commerce $2.9M–$190M
Nissay Capital
VC Fund
4 Japan, United States Seed, Series A Health Care, Internet, Medical $925k–$69M
UTokyo Innovation Platform
VC Fund
4 Japan, United States, United Kingdom Series A, Seed Biotechnology, Medical, Health Care $7.9M–$275M
Sunland Fund
VC Fund
4 China Series A, Series B, Seed Health Care, Medical, Biotechnology $2.7M–$27M
Mitsubishi UFJ Capital
VC Fund
4 Japan, United States, China Series B, Series A Software, Health Care, Information Technology $11M–$330M
SND Ventures Group
VC Fund
4 China Series A, Series B, Angel Manufacturing, Medical, Health Care $412k–$41M
Med-Fine Capital
VC Fund
4 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical $2.7M–$50M
Dalton Venture
VC Fund
4 China Series A, Series B, Angel Health Care, Medical, Medical Device $2.7M–$21M
Prox Ventures
VC Fund
4 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care
CASH Capital
VC Fund
3 China, United States Series A, Series B, Series C Health Care, Biotechnology, Manufacturing $1.4M–$151M
Source Code Capital
VC Fund
3 China, United States, Spain Series B, Series A, Series C Software, E-Commerce, Artificial Intelligence $1.4M–$200M
Fortune Venture Capital
VC Fund
3 China, Japan, United States Series A, Series B, Series C Manufacturing, Information Technology, Health Care $1.4M–$220M
Redhill Capital
VC Fund
3 China Seed, Series A Health Care, Medical, Medical Device $1.4M–$24M
Oriza Seed Capital (Oriza Yuandian)
VC Fund
3 China, United States Series A, Angel, Seed Health Care, Manufacturing, Biotechnology
SBI Investment
VC Fund
3 Japan, South Korea, United States Series B, Series A Financial Services, Information Technology, Software $5.9M–$302M
Volcanics Venture
VC Fund
3 China, United States Series A, Series B, Seed Health Care, Biotechnology, Software $350k–$30M
Long Hill Capital
VC Fund
3 China, United States Series A, Series B, Angel Medical, Health Care, Training $1.4M–$100M
Oriental Fortune Capital
VC Fund
3 China, United States Series A, Series B, Seed Software, Information Technology, E-Commerce $412k–$100M
Shunwei Capital
VC Fund
3 China, India, United States Series A, Series B, Series C Internet, E-Commerce, Software $1.4M–$99M
CMB International Capital Corporation
VC Fund
3 China, United States, Japan Series B, Series A, Series C Biotechnology, Health Care, Manufacturing $13M–$453M
Highlight Capital
VC Fund
3 China, United States, Portugal Series A, Series B, Series C Health Care, Biotechnology, Medical $2.7M–$200M
Cenova
VC Fund
3 China, Singapore, United States Series B, Series A, Series C Health Care, Medical, Pharmaceutical $1.4M–$100M
Huagai Capital
VC Fund
3 China, United States, Hong Kong Series A, Series B, Angel Health Care, Biotechnology, Medical $412k–$90M
Prosperico Ventures
VC Fund
3 China, United States Series A, Series B, Seed Medical, Health Care, Biotechnology $4.1M–$150M
Keio Innovation Initiative
VC Fund
3 Japan Seed, Series A Medical, Health Care, Biotechnology $12M–$100M
EFung Capital
VC Fund
3 China, United States, India Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $1.4M–$84M
Shenzhen Capital Group
VC Fund
3 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Software $1.4M–$604M
Jinding Capital
VC Fund
3 China Series A, Series B, Seed Manufacturing, Health Care, E-Commerce $1.4M–$55M
Oriza Holdings
VC Fund
3 China, United States, Canada Series A, Series B, Series C Health Care, Biotechnology, Manufacturing $1.4M–$300M
Legend Star
VC Fund
2 China, United States, France Series A, Angel, Seed Health Care, Medical, Biotechnology $412k–$30M
6 Dimensions Capital
VC Fund
2 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $1.4M–$300M
CCB International
VC Fund
2 China, United States, Hong Kong Series C, Series A, Series B Health Care, Biotechnology, Medical $1.5M–$4.5B
Grand Mount Capital
VC Fund
2 China, France Series B, Series A, Angel Biotechnology, Medical, Health Care $14M–$31M
Dingxin Capital
VC Fund
2 China Series A, Series B, Seed Medical, Health Care, Biotechnology $1.4M–$14M
iSGS Investment Works
VC Fund
2 Japan, United States, Hong Kong Seed, Series A E-Commerce, Software, Information Technology $730k–$56M
Access all 50 investors in Asia Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Sequoia Capital China
VC Fund · Beijing, Beijing, China · 10 investments in Asia Medical Device startups, 56 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Australia

Investor stats

  • Total investments: 643
  • Round size: Series A $4M–$90M; Series B $11M–$172M; Series C $25M–$200M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • FUE Bioscience — FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.
  • Life Wilderness — Life Wilderness reimagines human-computer interaction and is linked to the transportation and travel industries.
  • Xintu Heterogeneous — Xintu Heterogeneous offers data storage solutions for heterogeneous computing.
Show all investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 10 investments in Asia Medical Device startups, 59 in the past 12 months

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 487
  • Round size: Series A $4.1M–$48M; Series B $10M–$100M; Series C $16M–$148M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Atantares — We are a development stage startup enabling the next generation of precision medicine by fusing biochip and AI technologies.
  • Saints Sages Medical — Saints Sages Medical is engaged in the production and sales of minimally invasive surgical medical devices. They have several energy device products that are widely used in minimally invasive surgery, hepatobiliary surgery, gynecology, urology, thoracic surgery, and other departments. Saints Sages closely monitors clinical needs and develops moreinnovative minimally invasive surgical devices to serve global patients, relying on a professional research and development team and years of the clinical transformation experience.
  • Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
Show all investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 9 investments in Asia Medical Device startups, 27 in the past 12 months

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 168
  • Round size: Series A $4.1M–$34M; Series B $6.9M–$50M; Series C $4.1M–$100M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • SIRUN — SIRUN is a provider and operator of Internet of Vehicles system services, alongside a manufacturer of passenger and commercial vehicles.
  • Anpaixin — Anpaixin manufactures thin-film lithium niobite photonic circuits and optical engines.
  • Xungene Therapeutics — Xunjing Biotech creates RNA-targeting small molecule medicines. The company's goal is to create RNA-targeting small molecule therapeutics that target uncommon disorders and malignancies. It employs RNA structure detection and artificial intelligence technology with its own intellectual property rights to design, screen, and evaluate smallmolecule drugs, shorten the R&D cycle in a more efficient and smarter manner, improve development efficiency, and promote faster drug marketing.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 9 investments in Asia Medical Device startups, 7 in the past 12 months

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Angel
  • Geography: China, United States

Investor stats

  • Total investments: 51
  • Round size: Angel $412k–$14M; Series A $1.4M–$15M; Series B $6.9M–$34M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Kanova — Kanova is a biopharmaceutical firm.
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 8 investments in Asia Medical Device startups, 21 in the past 12 months

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 163
  • Round size: Series A $11M–$69M; Series B $21M–$100M; Series C $27M–$275M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Akura Medical — Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots.
  • Precede Biosciences — Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. Discover how we are helping create a world where medicine is developed more successfully, and every diagnosis is precise and minimally invasive.
  • LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Show all investments...

Haibang Capital
VC Fund · Hangzhou, Zhejiang, China · 8 investments in Asia Medical Device startups

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Angel, Series B
  • Geography: China

Investor stats

  • Total investments: 34
  • Round size: Angel $412k–$2.7M; Series A $1.4M–$14M; Series B $10M–$69M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
  • LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
  • Zhongzhiwei Technology — Zhongzhiwei Technology is a new generation of artificial intelligence + machine learning-driven network security collaborative operation solution provider
Show all investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 7 investments in Asia Medical Device startups

BioTrack Capital is a China-based investment firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 47
  • Lead/follow: no public data

Portfolio highlights

  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Qitan Technology — Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenientinstrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
Show all investments...

Addor Capital
VC Fund · Nanjing, Jiangsu, China · 6 investments in Asia Medical Device startups, 48 in the past 12 months

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Electronics
  • Stage:Series A, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 166
  • Round size: Series A $1.4M–$27M; Series B $2.7M–$41M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Superfuse — Superfuse specializes in R&D and production of high-performance fuse products & new generation Pyrofuse instantaneous breaker products for new energy vehicles, charging piles, wind and solar storage, two-wheeled vehicles, electric ships, data centers.
  • Aikeda Bio — Aikeda Bio provides R&D production, sales and technical services. Its products cover coagulation detection systems, specific protein detection systems, reproductive detection systems and immune detection systems
  • Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 6 investments in Asia Medical Device startups, 33 in the past 12 months

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 277
  • Round size: Series A $2.7M–$50M; Series B $11M–$110M; Series C $15M–$200M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
  • Saige Research — Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control. The company provides a deep learning vision inspection platform optimized for the manufacturing industry to solve inspectors' difficulties and increase work efficiency; its technology provides power detection, speed detection, wideversatility, and development convenience.
  • Ligatech Bioscience — Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. Andprovide users with relevant technical advice and technical services.
Show all investments...

Marathon Venture Partners
VC Fund · Shanghai, Shanghai, China · 5 investments in Asia Medical Device startups, 7 in the past 12 months

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Angel
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 43
  • Round size: Angel $412k–$3M; Series A $1.4M–$16M; Series B $14M–$462M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
  • Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SZHTI Group
VC Fund · Shenzhen, Guangdong, China · 5 investments in Asia Medical Device startups, 36 in the past 12 months

SZHTI Group is a company that provides asset management and financing services.

Show more...

Investment focus

  • Industry: Manufacturing, Electronics, Health Care
  • Stage:Series A, Angel
  • Geography: China, United States

Investor stats

  • Total investments: 81
  • Round size: Angel $412k–$1.4M; Series A $755k–$14M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Biocatsyn — Biocatsyn offers synthetic biology solutions, along with R&D and green biomanufacturing of related products. Baikaisheng Biotechnology is located in Shanghai Lingang Nanqiao Science and Technology City (the core area of ​​Fengxian New Town).
  • Newdel Biotech — Newdel Biotech offers drug screening services along with biomedical technology development and consulting.
  • Yingfei Network — Yingfei Network is a data system developer that is working on the next generation of cloud-native-oriented seven-layer large-scale load balancing systems.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 5 investments in Asia Medical Device startups, 9 in the past 12 months

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Taiwan

Investor stats

  • Total investments: 76
  • Round size: Series A $2.7M–$41M; Series B $2.7M–$55M; Series C $14M–$58M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Xiguang Bio — Xiguang Bio focuses on the production of diagnostic reagents and provides chemiluminescent raw materials and overall system technology solutions.
  • Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
  • Panomic Biomedical Technology — Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolitepreprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.
Show all investments...

Nippon Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 5 investments in Asia Medical Device startups

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed
  • Geography: Japan, United States

Investor stats

  • Total investments: 124
  • Round size: Seed $6.9M–$112M; Series A $6.8M–$82M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Utill — Utill is anything that expands the possibilities of not only production but also our own services
  • LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.
  • LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Show all investments...

Share Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in Asia Medical Device startups

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 72
  • Round size: Angel $412k–$824k; Series A $1.4M–$10M; Series B $2.7M–$55M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Clounix — Clounix manufactures customizable silicon network chips and cloud native software technology solutions.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
  • Help Stem Cell Innovations — Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health.
Show all investments...

Taiyu Investment
VC Fund · Beijing, Beijing, China · 4 investments in Asia Medical Device startups

Taiyu Investment is an investment firm.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China

Investor stats

  • Total investments: 17
  • Round size: Seed $14M–$20M; Angel $412k–$412k; Series A $14M–$14M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
  • Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Show all investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 4 investments in Asia Medical Device startups, 24 in the past 12 months

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 611
  • Round size: Series A $2.9M–$100M; Series B $6.9M–$137M; Series C $15M–$190M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Infinimos — Infinimos is a Cosmos ecological liquid staking derivatives platform that aims to build a decentralized and democratized ecosystem capable of maximizing staking rewards while retaining liquidity.
  • Xbotspace — Xbotspace is the generative AI middleware startup investigates the implementation and deployment of huge language models.
  • Biotyx Medical — Biotyx Medical manufactures and sells iron-based biodegradable vascular materials and stents.
Show all investments...

Nissay Capital
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Asia Medical Device startups

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Show more...

Investment focus

  • Industry: Health Care, Internet, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States

Investor stats

  • Total investments: 147
  • Round size: Seed $925k–$55M; Series A $14M–$69M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Todoker — Todoker is a baggage delivery convenient service providing company.
  • LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
  • Beer and Tech — Beer and Tech operates a website for the Phalaenopsis or foliage plant HitoHana. Norihisa Morita and Yoshiaki Ito founded it in 2014, with its headquarters in Saitama in Japan.
Show all investments...

UTokyo Innovation Platform
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Asia Medical Device startups

The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $8.7M–$41M; Series A $7.9M–$275M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • BionicM — BionicM develops high-performance robot prostheses that enhance mobility for people with disabilities.BionicM has been conducting research on innovative technologies since 2015 at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba and utilizing the world's most advancedrobotics research. In 2016, we were adopted by the Japan Science and Technology Agency as part of "Program for Creating STart-ups from Advanced Research and Technology" (START), and in 2018, the company was established as a joint-stock company.
  • Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
  • Logomix Inc. — Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas.
Show all investments...

Sunland Fund
VC Fund · Shanghai, Shanghai, China · 4 investments in Asia Medical Device startups, 7 in the past 12 months

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 15
  • Round size: Series A $11M–$14M; Series B $2.7M–$27M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Jiyuan Medical — Jiyuan Medical focuses on disposable gynecological endoscopes and peripheral products. Its products include disposable electronic hysteroscopes (including 4K high-definition mirrors, resectoscopes, fluoroscopes, near-infrared mirrors, and NBI mirrors), disposable gynecological minimally invasive surgical instruments, hysteroscopes Intelligentworkstations, disposable fetoscopes, and disposable mammoscopes to create an overall solution for disposable gynecological endoscopes based on disposable electronic hysteroscopes.
  • BD Gene Therapeutics — BD Gene Therapeutics is a provider of a gene-editing platform for the treatment of genetic diseases. It uses mRNA delivery technology to achieve safe and efficient delivery of gene-editing tools such as CRISPR. In addition, BD-mRNA technology has important application prospects in the fields of tumor immunity and regenerative medicine. It also usesthe fourth-generation lentiviral vector platform for all types of cells. It has developed antiviral eyedrops and others.
  • Hexin Pharmaceutical — Hexin Pharmaceutical is a developer of nuclide drugs integrating targeted diagnosis and treatment.
Show all investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Asia Medical Device startups, 9 in the past 12 months

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series A
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 259
  • Round size: Series A $11M–$96M; Series B $12M–$330M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
  • CADDi — CADDi is an online ordering platform for manufacturing industry.
  • EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SND Ventures Group
VC Fund · Suzhou, Jiangsu, China · 4 investments in Asia Medical Device startups, 14 in the past 12 months

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Series B, Angel
  • Geography: China

Investor stats

  • Total investments: 37
  • Round size: Angel $412k–$412k; Series A $1.4M–$41M; Series B $687k–$24M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Jinengyi — Jinengyi specializes in long-term intelligent monitoring and solar system power optimization. It is a developer of photovoltaic power plant inverters and monitoring communication systems.
  • Zozen — Zhuzheng Robotics is a medical robot manufacturer and developer specializing in minimally invasive spinal surgery. It specializes in researching new, intelligent, high-end medical devices with independent intellectual property rights, researching and developing products related to minimally invasive spinal surgery, and providing related services.
  • Runchengda Power — Runchengda Power focuses on research and deelopment, manufacturing, and sales of smart car charging pile and digital energy solutions.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 4 investments in Asia Medical Device startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 52
  • Round size: Seed $8M–$21M; Series A $2.7M–$20M; Series B $11M–$50M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 4 investments in Asia Medical Device startups, 7 in the past 12 months

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Angel
  • Geography: China

Investor stats

  • Total investments: 28
  • Round size: Series A $2.7M–$16M; Series B $2.7M–$21M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
  • Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 4 investments in Asia Medical Device startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 46
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • VacV Biotech — VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety andefficiency and can be administered by intravenous injection.
  • HROCT LITT Medtech — HROCT LITT Medtech has developed the unique SNP(Smart Needle Probe) needle imaging, assembled as a catheter, which OD is smaller than 1/5 of the traditional invasive OCT catheter, while the depth and resolution are all multiple times of the traditional invasive OCT catheter, achieving 1um level to supply the histopathology needed microimaging.The fiber could be compatible with different kinds of biopsy needles to access the targets, and also could be coupled with a specific laser to achieve OCT situ diagnosis and laser ablation. Its technology provides revolutionary solutions to neurosurgery, interventional pulmonology, neurovascular, nephropathy, mammary gland, cardiac, GI, and other fields.
Show all investments...

CASH Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Medical Device startups

CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Series C
  • Geography: China, United States

Investor stats

  • Total investments: 71
  • Round size: Series A $1.4M–$30M; Series B $14M–$41M; Series C $4.1M–$151M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • AKA Robotics — AKA Robotics developer special robots, industrial robots, intelligent equipment, and other technologies. It mainly provides professional solutions such as rust removal, cleaning, deicing, testing, spraying, and grinding for industries such as ships, petrochemicals, wind power, offshore platforms, and steel structure bridges.AKA Robotics aims tocompletely free workers from harsh working environments such as high risk and high pollution, help enterprises transform and upgrade, and achieve the goal of green development.
  • Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
  • Boardstone Intelligence — Boardstone Intelligence is a provider of precision 3D inspection solutions and laboratory analysis solutions.
Show all investments...

Source Code Capital
VC Fund · Chaoyang, Liaoning, China · 3 investments in Asia Medical Device startups, 18 in the past 12 months

Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Artificial Intelligence
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Spain

Investor stats

  • Total investments: 200
  • Round size: Series A $1.4M–$41M; Series B $14M–$90M; Series C $30M–$200M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Legendsemi — Legendsemi focuses on the development and design of high-performance analog and mixed-signal chips.
  • Minghao Technology — Minghao Technology is a comprehensive solution provider for optometry.
  • Unisun Energy Group — Unisun Energy is a globalized photovoltaic technology solution provider, Unisun's eminent services rely on its effecient cost control, professional technology team, abundant project and financial resources, front-edge data analysis and reassuring O&M.
Show all investments...

Fortune Venture Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Medical Device startups, 20 in the past 12 months

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: China, Japan, United States

Investor stats

  • Total investments: 157
  • Round size: Series A $1.4M–$14M; Series B $4.5M–$52M; Series C $2.9M–$220M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Aorui Bio — Aorui Bio is a biotech R&D company that combines whole genome liquid biopsy and ML tech for wireless cancer early screening technology.
  • Fmeamaster — Fmeamaster a developer of digital technologies for quality risk management and control, brings together top FMEA specialists and IT technical experts in the industry, focusing on the creation and implementation of FMEA software solutions and the research of FMEA theoretical techniques.
  • Zhonghui Laser — Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.
Show all investments...

Redhill Capital
VC Fund · Guangzhou, Guangdong, China · 3 investments in Asia Medical Device startups

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A
  • Geography: China

Investor stats

  • Total investments: 24
  • Round size: Seed $1.4M–$14M; Series A $2.9M–$24M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • Douli — Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.
  • Xianwei Medical — Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment.
  • EnCureGen Pharmaceuticals — Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.
Show all investments...

Oriza Seed Capital (Oriza Yuandian)
VC Fund · Suzhou, Jiangsu, China · 3 investments in Asia Medical Device startups, 6 in the past 12 months

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Series A, Angel, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 74
  • Lead/follow: no public data

Portfolio highlights

  • Aerofugia — Aerofugia is a technology company with low-altitude travel and vehicle-mounted flight as its core, and a practitioner of the new general aviation strategy under Geely Technology Group.
  • Guoshun Laser — Guoshun Laser is a developer of high-power ultrafast micro-nano structure fiber lasers.
  • clearing zero carbon — Clean Capture is an innovative company that uses artificial technology and provides low-cost carbon removal technology solutions through the research and development and commercialization of carbon capture, utilization and storage (CCUS) technology.
Show all investments...

SBI Investment
VC Fund · Minato, Chiba, Japan · 3 investments in Asia Medical Device startups, 13 in the past 12 months

SBI Investment supports the business development and growth of private venture companies through fund investment.

Show more...

Investment focus

  • Industry: Financial Services, Information Technology, Software
  • Stage:Series B, Series A
  • Geography: Japan, South Korea, United States

Investor stats

  • Total investments: 232
  • Round size: Series A $6M–$179M; Series B $5.9M–$302M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2020

Portfolio highlights

  • Edgecortix — At Edgecortix, we automate the design of AI accelerators for on-device deep learning. Our Dynamic Neural Accelerator IP, and performance optimized AI Software & Hardware Co-exploration framework, reduces time to market and brings massive cost savings across multiple industry verticals.
  • Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
  • Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Volcanics Venture
VC Fund · Changning, Shanghai, China · 3 investments in Asia Medical Device startups

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 84
  • Round size: Seed $350k–$14M; Series A $1.4M–$14M; Series B $5.5M–$30M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
  • Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Show all investments...

Long Hill Capital
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Medical Device startups

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

Show more...

Investment focus

  • Industry: Medical, Health Care, Training
  • Stage:Series A, Series B, Angel
  • Geography: China, United States

Investor stats

  • Total investments: 26
  • Round size: Series A $1.4M–$20M; Series B $20M–$100M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
  • Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
  • Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Medical Device startups, 18 in the past 12 months

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 166
  • Round size: Seed $412k–$41M; Series A $1.4M–$27M; Series B $2.7M–$100M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Microtreat — Microtreat specializes in the research, development, manufacturing, and sale of different high-end industrial application ultra-precision laser equipment, particularly equipment based on infrared, ultraviolet, green light, and ultra-short pulse technology, which is mostly utilized in the field of thin-film solar energy.
  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Pinfeng Medical — Pinfeng Medical is a platform firm that integrates independent research and development, manufacturing, marketing, and service to provide high-quality intelligent testing and precise diagnostic solutions to the local and international in vitro diagnostic industries.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Medical Device startups, 21 in the past 12 months

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.

Show more...

Investment focus

  • Industry: Internet, E-Commerce, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, India, United States

Investor stats

  • Total investments: 301
  • Round size: Series A $1.4M–$30M; Series B $10M–$50M; Series C $20M–$99M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • Xinsu Technology — Xinsu Technology develops, designs, and sells industrial machine vision sensor devices. It is specialized in new energy battery and automobile manufacturing industries. It engaged in intellectual property rights of decoding and reading algorithms and has launched a series of industrial high-performance fixed code readers such as R275-A.
  • Ant Workshop — Ant Works is an e-commerce platform integrating industrial automation products, the Internet, and supply chain services.It aims to build a new industrial product marketing method with "industrial cloud components + Internet + supply chain SAAS services" as the main body. An integrated platform for online and offline transactions,services, and support. It has the characteristics of high cost performance, authentic guarantee, fast shipping, free 3D download, and so on. Through diversified product categories and sufficient inventory, customers can efficiently search for and purchase suitable products.
  • Yixin Technology — Yixin Technology focuses on R&D of image software, with the goal of flattening image processing technology to promote the design revolution.
Show all investments...

CMB International Capital Corporation
VC Fund · Central, Hong Kong Island, Hong Kong · 3 investments in Asia Medical Device startups, 11 in the past 12 months

CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 89
  • Round size: Series A $13M–$453M; Series B $14M–$270M; Series C $34M–$300M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Hongdao New Materials — Hongdao New Materials is a technology-based company that specializes in the research, development, production, and sale of solar module packaging film materials.
  • Neurophth Therapeutics — Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
  • Red Sun Optoelectronics — Red Sun Optoelectronics is a state-owned high-tech enterprise specializing in photovoltaic equipment, intelligent manufacturing system integration applications, R&D, and production.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 3 investments in Asia Medical Device startups, 6 in the past 12 months

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Portugal

Investor stats

  • Total investments: 92
  • Round size: Series A $2.7M–$26M; Series B $2.7M–$70M; Series C $16M–$200M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Etana — PT Etana Biotechnologies Indonesia (Etana) is an emerging producer of high-quality, affordable and innovative biopharmaceuticals to treat a range of metabolic, autoimmune and other major life-threatening diseases, including cancer. Nathan Tirtana. Legend Capital. UOB Venture Management. Innovent Bio
  • Hongyixin — Hongyixin is an automotive electronic chip developer.
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
Show all investments...

Cenova
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Medical Device startups

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: China, Singapore, United States

Investor stats

  • Total investments: 32
  • Round size: Series A $1.4M–$38M; Series B $2.7M–$61M; Series C $27M–$100M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
  • Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
  • Hunan Yiyi Pharmaceutical Technology — Hunan Yiyi Pharmaceutical Technology
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Medical Device startups, 9 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 110
  • Round size: Angel $412k–$1.3M; Series A $1.4M–$60M; Series B $3.5M–$90M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
  • Leaf Biotech — Leaf Biotech is a research and development, production and sales of green chemical-related materials and series intermediates. The business produces biomass resources. The focus of the research and development is the bio-based polyester material PEF and important intermediates, as well as the creation of green drugs and intermediates for healthcareproducts.
  • Dingzhi Biotech — Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.
Show all investments...

Prosperico Ventures
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Medical Device startups

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 13
  • Round size: Series A $4.1M–$60M; Series B $8.9M–$150M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Cytocares — Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
  • KingstronBio — KingstronBio manufactures artificial heart valves and annuloplasty rings.
  • Jiaohong Biology — Jiaohong Biology is a molecular diagnostic technology research and development and application service provider.
Show all investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Medical Device startups

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 43
  • Round size: Seed $12M–$55M; Series A $49M–$100M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
  • Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
  • Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
EFung Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Medical Device startups, 7 in the past 12 months

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 42
  • Round size: Series A $1.4M–$76M; Series B $15M–$84M; Series C $14M–$69M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Turno — Turno Finance makes owning EV very affordable. Turno Club is a community around commercial EVs. Turno Battery Future is our solution to keeping batteries on the road for longer.
  • IASO Biotherapeutics — IASO Biotherapeutics (IASO BIO) is a Nanjing-based biopharmaceutical company focused on the discovery, development and commercialization of cell therapies in the field of oncology.
  • Huayuan Regenerative Medicine — Huayuan Regenerative Medicine is a developer of implantable biological artificial organs.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Medical Device startups, 13 in the past 12 months

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 241
  • Round size: Series A $1.4M–$604M; Series B $2.7M–$137M; Series C $3.9M–$137M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Cybernetics — Cybernetics is a producer of digital energy solutions and products based on electrical measuring technology.
  • Changyang Software — Changyang Software adheres to the concept of independent innovation, focuses on the field of national basic software security, develops a series of secure operating system products, and performs migration and adaptation, reconstruction, independent research and development of Xinchuang products, and security solution design and implementation.
  • Runpeng Semiconductor — Runpeng Semiconductor is a chip and integrated circuit producer and developer.
Show all investments...

Jinding Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Medical Device startups, 17 in the past 12 months

Jinding Capital is a leading industrial equity investment institution in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, E-Commerce
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 36
  • Round size: Series A $1.4M–$30M; Series B $6.9M–$55M
  • Lead/follow: 49% lead, 51% follow

Portfolio highlights

  • Jinengyi — Jinengyi specializes in long-term intelligent monitoring and solar system power optimization. It is a developer of photovoltaic power plant inverters and monitoring communication systems.
  • Tengchuang — Tengchuang is an animal health pharmaceutical company specializing in improving the standard of animal healthcare.
  • AIMIRA Innovation Technology — AIMIRA Innovation Technology is an AI-based medical technology company that offers diagnosis, aesthetic plastic surgery, and anti-aging medicine.
Show all investments...

Oriza Holdings
VC Fund · Suzhou, Jiangsu, China · 3 investments in Asia Medical Device startups, 15 in the past 12 months

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 125
  • Round size: Series A $1.4M–$38M; Series B $10M–$100M; Series C $19M–$300M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • HIGEC — HIGEC focuses on the research and development, production, sales and after-sales service of automobile parts.
  • Guoshun Laser — Guoshun Laser is a developer of high-power ultrafast micro-nano structure fiber lasers.
  • Juxing Technology — Juxing Technology is a national high-tech firm that develops intelligent, information-based teaching and management software based on artificial intelligence and virtual reality technology.
Show all investments...

Legend Star
VC Fund · Beijing, Beijing, China · 2 investments in Asia Medical Device startups

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Angel, Seed
  • Geography: China, United States, France

Investor stats

  • Total investments: 115
  • Round size: Seed $1.4M–$19M; Angel $412k–$6.9M; Series A $1.4M–$30M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • CoJourney — CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.
  • Carbon Energy Technology — Carbon Energy Technology develops technology for carbon utilization and its commercialization.
  • China Reserve National Energy — China Reserve National Energy is a developer of air energy storage technology. This technology has the advantages of large scale, low cost, long life, clean and pollution-free, unlimited energy storage period, independent of fossil fuels and geographical conditions, etc.
Show all investments...

6 Dimensions Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Medical Device startups

6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 46
  • Round size: Series A $1.4M–$150M; Series B $30M–$260M; Series C $151M–$300M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Exo Therapeutics — Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential toreprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.
  • Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.
  • Ignis Therapeutics — Ignis Therapeutics is a innovative therapies in the field of central nervous system.
Show all investments...

CCB International
VC Fund · Central, Hong Kong Island, Hong Kong · 2 investments in Asia Medical Device startups

CCB International (Holdings) Limited and its subsidiaries (CCB International) is an investment services flagship which is owned by China Construction Bank Corporation ("CCB"). Its core business is divided into three main areas, namely Pre-IPO, IPO and Post-IPO which in turn form a comprehensive investment services value chain that offersa full range of products, and services including sponsoring and underwriting, financial advisory, corporate mergers and acquisitions and restructuring, additional issuance and placement of shares and refinancing forlisted companies, direct investment, asset management, securities brokerage, market research, investment consultancy, etc.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series C, Series A, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 68
  • Round size: Series A $1.5M–$300M; Series B $2.7M–$4.5B; Series C $70M–$150M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Thor Innovation — Thor Innovation is a high-tech enterprise mainly engaged in haptics, an electronic simulation of tactile sense.
  • Dongfang Jingyuan Electron — Dongfang Jingyuan Electron Ltd is a semiconductor equipment and software company that focuses on integrated circuit production management.
  • Hangzhou Times Electric Technology — Times Electric is a developer of new energy vehicles and core components.
Show all investments...

Grand Mount Capital
VC Fund · 2 investments in Asia Medical Device startups

Grand Mountain Capital or to discuss a specific investment opportunity.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series A, Angel
  • Geography: China, France

Investor stats

  • Total investments: 7
  • Round size: Series A $14M–$31M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Qinghan Medical — Qinghan Medical is a medical equipment research and development manufacturer
  • Zhenzhun Biotech — It is a bio-tech enterprise integrating R&D, production and sales of in vitro diagnostic equipment consumables. Life and health business. The core team includes both enterprise management experts from leading medical device companies in the world, as well as scientists and technical experts in micro-nano processing, precision instruments, imagealgorithms, and biological reagents. We have successfully developed China's first chip-type digital PCR instrument with independent intellectual property rights. 臻Quan Biotechnology is in the stage of rapid development, and we invite talented people to join us to create a great cause!
  • Spectrum Medical — Spectrum Medical is a clinical mass spectrometry product platform in the field of medical clinical testing
Show all investments...

Dingxin Capital
VC Fund · Shenzhen, Guangdong, China · 2 investments in Asia Medical Device startups

Dingxin Capital is an investment management agency that specializes in equity investments. The partners are mainly from domestic first-line investment institutions such as CDH, Jiuding and Zhongjin. They have deep accumulation and rich experience in the equity investment field, paying attention to the construction of the whole organization andtrying to build a truly sustainable competition. Investment institutions.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 18
  • Round size: Series A $1.4M–$14M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Semitech — Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.
  • Legendsemi — Legendsemi focuses on the development and design of high-performance analog and mixed-signal chips.
  • Ai Ma Biology — Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.
Show all investments...

iSGS Investment Works
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Asia Medical Device startups

iSGS Investment Works is Japan-based venture capital firm.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: Japan, United States, Hong Kong

Investor stats

  • Total investments: 50
  • Round size: Seed $730k–$48M; Series A $19M–$56M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • BABY JOB — BABY JOB offers nursery support and child care support businesses.
  • SOUNDRAW — Your personal AI music generator.
  • Startbahn — Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We alsorun joint projects with other companies.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Asia Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists